Table 2 Body mass index, excess weight loss, and percent total body weight loss at 6-months follow-up for study participants undergoing either ESG or SG procedure
|  | BMI | EWL (%) | Reinhold Classification | TBWL (%) | TBWL < 20% | TBWL ≥ 20% | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EWL < 25% | EWL 25–49.9% | EWL 50–74.9% | EWL ≥ 75% | |||||||||
n | Mean (SD) | n | Mean (SD) | n (%) | n (%) | n (%) | n (%) | n | Mean (SD) | n (%) | n (%) | |
ESG | ||||||||||||
 6-month follow-up | 13 | 30.5 (2.9)*** | 13 | 51 (11)*** | 0 (0) | 6 (46.2) | 7 (53.8) | 0 (0) | 13 | 15 (6)*** | 11 (84.6) | 2 (15.4) |
 12-month follow-up | 9 | 29.9 (3.6)** | 9 | 57 (32)** | 2 (22.2) | 2 (22.2) | 2 (22.2) | 3 (33.3) | 9 | 18 (11)** | 4 (44.4) | 5 (55.6) |
LSG | ||||||||||||
 6-month follow-up | 41 | 31.4 (5.1)*** | 41 | 66 (25)*** | 0 (0) | 11 (26.8) | 17 (41.5) | 13 (31.7) | 41 | 24 (6)*** | 11 (26.8) | 30 (73.2) |
 12-month follow-up | 36 | 29.2 (5.1)*** | 36 | 79 (24)*** | 1 (2.8) | 3 (8.3) | 12 (33.3) | 20 (55.6) | 36 | 30 (8)*** | 4 (11.1) | 32 (88.9) |